Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33 (2): 160-172. 10.1002/art.1780330203.
Article
CAS
PubMed
Google Scholar
White KP, Harth M: Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep. 2001, 5 (4): 320-329. 10.1007/s11916-001-0021-2.
Article
CAS
PubMed
Google Scholar
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB: The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010, 62 (5): 600-610. 10.1002/acr.20140.
Article
Google Scholar
Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004, 50 (9): 2974-2984. 10.1002/art.20485.
Article
CAS
PubMed
Google Scholar
Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005, 119 (1–3): 5-15.
Article
CAS
PubMed
Google Scholar
Basbaum AI, Fields HL: Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984, 7: 309-338. 10.1146/annurev.ne.07.030184.001521.
Article
CAS
PubMed
Google Scholar
Clark FM, Proudfit HK: The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception. Brain Res. 1993, 616 (1–2): 200-210.
Article
CAS
PubMed
Google Scholar
Coderre TJ, Katz J: Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain. Behav Brain Sci. 1997, 20 (3): 404-419.
CAS
PubMed
Google Scholar
Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA: Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol. 1992, 19 (1): 104-109.
CAS
PubMed
Google Scholar
Staud R, Rodriguez ME: Mechanisms of disease: pain in fibromyalgia syndrome. Nature Clinical Practice. Rheumatology. 2006, 2 (2): 90-98.
PubMed
Google Scholar
Yunus MB: Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007, 36 (6): 339-356. 10.1016/j.semarthrit.2006.12.009.
Article
PubMed
Google Scholar
Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA: Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry. 2002, 63 (4): 308-315. 10.4088/JCP.v63n0407.
Article
CAS
PubMed
Google Scholar
Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA: Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res. 2002, 36 (6): 383-390. 10.1016/S0022-3956(02)00060-2.
Article
PubMed
Google Scholar
Koponen H, Allgulander C, Erickson J, Dunayevich E, Pritchett Y, Detke MJ, Ball SG, Russell JM: Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians. Prim Care Companion J Clin Psychiatry. 2007, 9 (2): 100-107. 10.4088/PCC.v09n0203.
Article
PubMed
PubMed Central
Google Scholar
Arnold LM: Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med. 2007, 8 (Suppl 2): S63-S74.
Article
PubMed
Google Scholar
Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM: Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008, 136 (3): 432-444. 10.1016/j.pain.2008.02.024.
Article
CAS
PubMed
Google Scholar
Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF: A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005, 6 (5): 346-356. 10.1111/j.1526-4637.2005.00061.x.
Article
PubMed
Google Scholar
Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J: A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006, 67 (8): 1411-1420. 10.1212/01.wnl.0000240225.04000.1a.
Article
CAS
PubMed
Google Scholar
Chappell AS, Bradley LA, Wiltse C, D’Souza DN, Späth M: Duloxetine 60–120 mg Versus Placebo in the Treatment of Fibromyalgia Syndrome [Poster]. 2007, Boston, MA, USA: ACR
Google Scholar
Choy E, Mease P, Kajdasz D, Wohlreich M, Walker D, Chappell A: Safety and Tolerability of Duloxetine in the Treatment of Patients With Fibromyalgia: Analysis of 5 Studies [Poster]. 2008, Tampa, FL, USA: Presented at the American Pain Society
Google Scholar
Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS: Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum. 2010, 39 (6): 454-464. 10.1016/j.semarthrit.2008.11.001.
Article
CAS
PubMed
Google Scholar
Wilson HD, Robinson JP, Turk DC: Toward the identification of symptom patterns in people with fibromyalgia. Arthritis Rheum. 2009, 61 (4): 527-534. 10.1002/art.24163.
Article
PubMed
PubMed Central
Google Scholar
Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991, 18 (5): 728-733.
CAS
PubMed
Google Scholar
Cleeland CS, Ryan KM: Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994, 23 (2): 129-138.
CAS
PubMed
Google Scholar
Ware JE, Snow KK, Kosinski M, Gandeck B: SF-36 Health Survey Manual and Interpretation Guide. 1993, Boston (MA): The Health Institute, New England Medical Center
Google Scholar
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry. 1961, 4: 561-571. 10.1001/archpsyc.1961.01710120031004.
Article
CAS
PubMed
Google Scholar
Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised. 1976, Rockville (MD): US Department of Health, Education, and Welfare Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs
Google Scholar
Sheehan DV: The Anxiety Disease. 1983, New York, NY: Charles Scribner and Sons
Google Scholar
Taft C, Karlsson J, Sullivan M: Do SF-36 summary component scores accurately summarize subscale scores?. Qual Life Res. 2001, 10 (5): 395-404. 10.1023/A:1012552211996.
Article
CAS
PubMed
Google Scholar
Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960, 23: 56-62. 10.1136/jnnp.23.1.56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Everitt BS: Cluster Analysis. 1993, London: Edward Arnold, 3
Google Scholar
Lipkovich IA, Smith EP: Biplot and SVD macros for EXCEL. J Stat Soft. 2002, 7: 5-
Article
Google Scholar
Hubert L, Arabie P: Comparing partitions. J Classif. 1985, 2: 193-218. 10.1007/BF01908075.
Article
Google Scholar
Sugar CA, James GM: Finding the number of clusters in a dataset: An information-theoretic approach. J Am Stat Assoc. 2003, 98: 750-763. 10.1198/016214503000000666.
Article
Google Scholar
Breiman L, Friedman JH, Olshen RA, Stone CJ: Classification and Regression Trees. 1984, Wadsworth, Belmont: Chapman and Hall/CRC
Google Scholar
Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, Da Silva JA, Danneskiold-Samsøe B, Dincer F, Henriksson C, Henriksson KG, Kosek E, Longley K, McCarthy GM, Perrot S, Puszczewicz M, Sarzi-Puttini P, Silman A, Späth M, Choy EH, EULAR: EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008, 67 (4): 536-541.
Article
CAS
PubMed
Google Scholar
Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, Gracely RH, Clauw DJ: Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003, 48 (10): 2916-2922. 10.1002/art.11272.
Article
PubMed
Google Scholar
De Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S: Fibromyalgia subgroups: profiling distinct subgroups using the fibromyalgia impact questionnaire. A preliminary study. Rheumatol Int. 2009, 29 (5): 509-515. 10.1007/s00296-008-0722-5.
Article
PubMed
Google Scholar
Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A: Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. Int Clin Psychopharmacol. 2011, 26 (2): 75-83. 10.1097/YIC.0b013e328341bb5f.
Article
PubMed
Google Scholar
Sagman D, McIntosh D, Lee MS, Li H, Ruschel S, Hussain N, Granger RE, Lee AC, Raskin J: Attributes of response in depressed patients switched to treatment with duloxetine. Int J Clin Pract. 2011, 65 (1): 73-81. 10.1111/j.1742-1241.2010.02546.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sheehan DV, Chokka PR, Granger RE, Walton RJ, Raskin J, Sagman D: Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine. Hum Psychopharmacol. 2011, 26 (3): 242-251.
CAS
PubMed
Google Scholar
van Koulil S, van Lankveld W, Kraaimaat FW, van Helmond T, Vedder A, van Hoorn H, Donders R, de Jong AJ, Haverman JF, Korff KJ, van Riel PL, Cats HA, Evers AW: Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. Arthritis Care Res (Hoboken). 2010, 62: 1377-1385. 10.1002/acr.20268.
Article
Google Scholar
van Koulil S, van Lankveld W, Kraaimaat FW, van Helmond T, Vedder A, van Hoorn H, Donders AR, Wirken L, Cats H, van Riel PL, Evers AW: Tailored cognitive-behavioural therapy and exercise training improves the physical fitness of patients with fibromyalgia. Ann Rheum Dis. 2011, 70 (12): 2131-2133. 10.1136/ard.2010.148577.
Article
CAS
PubMed
Google Scholar
Häuser W, Bernardy K, Arnold B, Offenbächer M, Schiltenwolf M: Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum. 2009, 61 (2): 216-224. 10.1002/art.24276.
Article
PubMed
Google Scholar